Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Jul;17(6):711-21.
doi: 10.1007/s10198-015-0716-7. Epub 2015 Aug 8.

Health resource utilization associated with skeletal-related events: results from a retrospective European study

Jean-Jacques Body  1 , João Pereira  2 , Harm Sleeboom  3 , Nikos Maniadakis  4 , Evangelos Terpos  5 , Yves Pascal Acklin  6 , Jindrich Finek  7 , Oliver Gunther  8 , Guy Hechmati  9 , Tony Mossman  10 , Luis Costa  11 , Wojciech Rogowski  12 , Hareth Nahi  13 , Roger von Moos  6
Affiliations
Comparative Study

Health resource utilization associated with skeletal-related events: results from a retrospective European study

Jean-Jacques Body et al. Eur J Health Econ. 2016 Jul.

Abstract

Background: Bone complications, also known as skeletal-related events (SREs), are common in patients with bone metastases secondary to advanced cancers.

Objective: To provide a detailed estimate of the health resource utilization (HRU) burden associated with SREs across eight European countries.

Methods: Eligible patients from centers in Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden, and Switzerland with bone metastases or lesions secondary to breast cancer, prostate, or lung cancer or multiple myeloma who had experienced at least one SRE (defined as radiation to bone, long-bone pathologic fracture, other bone pathologic fracture, surgery to bone or spinal cord compression) were entered into this study. HRU data were extracted retrospectively from the patients' charts from 3.5 months before the index SRE until 3 months after the index SRE (defined as an SRE preceded by an SRE-free period of at least 6.5 months).

Results: Overall, the mean number of inpatient stays per SRE increased from baseline by approximately 0.5-1.5 stays, with increases in the total duration of inpatient stays of approximately 6-37 days per event. All SREs were associated with substantial increases from baseline in the frequency of procedures and the number of outpatient and day-care visits.

Conclusions: SREs are associated with substantial HRU owing to considerable increases in the number and duration of inpatient stays, and in the number of procedures, outpatient visits, and day-care visits. These data collectively provide a valuable summary of the real-world SRE burden on European healthcare systems.

Keywords: Bone metastases; Breast cancer; Health resource utilization (HRU); Lung cancer; Prostate cancer; Skeletal-related event (SRE).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study design and data collection for patients with one SRE (a), and multiple SREs (b)
Fig. 2
Fig. 2
Mean (SD) change from baseline for number (a), and total duration (b) inpatient stays. PF pathologic fracture
Fig. 3
Fig. 3
Mean (SD) change from baseline for number of procedures. PF pathologic fracture
Fig. 4
Fig. 4
Mean (SD) change from baseline for number of outpatient visits (a) and number of day care visits (b). PF pathologic fracture
See this image and copyright information in PMC

References

    1. Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fossa SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall’Oglio M, Franzen L, Coleman R, Vogelzang NJ, O’Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland OS, Sartor O, Investigators A. Alpha emitter radium-223 and survival in metastatic prostate cancer. N. Engl. J. Med. 2013;369(3):213–223. doi: 10.1056/NEJMoa1213755. - DOI - PubMed
    1. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 2006;12(20 Pt 2):6243s–6249s. doi: 10.1158/1078-0432.CCR-06-0931. - DOI - PubMed
    1. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(8 Suppl):1588–1594. doi: 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G. - DOI - PubMed
    1. Costa L, Badia X, Chow E, Lipton A, Wardley A. Impact of skeletal complications on patients’ quality of life, mobility, and functional independence. Support. Care Cancer. 2008;16(8):879–889. doi: 10.1007/s00520-008-0418-0. - DOI - PubMed
    1. Norgaard M, Jensen AO, Jacobsen JB, Cetin K, Fryzek JP, Sorensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007) J. Urol. 2010;184(1):162–167. doi: 10.1016/j.juro.2010.03.034. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources